Skip to main content
Springer logoLink to Springer
. 2020 Sep 27;140(5):791. doi: 10.1007/s00401-020-02229-4

Correction to: ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

Charles E Evans 1,2,#, James S Miners 3,✉,#, Giulia Piva 2, Christine L Willis 4, David M Heard 4, Emma J Kidd 2, Mark A Good 1, Patrick G Kehoe 3,✉
PMCID: PMC7852865  PMID: 32980946

Correction to: Acta Neuropathologica (2020) 139:485–502 10.1007/s00401-019-02098-6

Unfortunately, the acknowledgement section was not included in the original publication. The complete acknowledgement section is given here.

Acknowledgements

This research was conducted thanks to an Alzheimer's Disease Research (ADR) project grant from the Bright Focus Foundation (A2016582S), Kehoe was supported by a Fellowship from the Sigmund Gestetner Foundation and Miners by an Alzheimer's Research UK Senior Research Fellowship.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

James S. Miners, Email: scott.miners@bristol.ac.uk

Patrick G. Kehoe, Email: Patrick.Kehoe@bristol.ac.uk


Articles from Acta Neuropathologica are provided here courtesy of Springer

RESOURCES